ADIL
Price
$1.73
Change
+$0.02 (+1.17%)
Updated
Apr 25, 6:59 PM EST
INZY
Price
$4.33
Change
-$0.07 (-1.59%)
Updated
Apr 25, 6:59 PM EST
11 days until earnings call
Ad is loading...

Compare predictions ADIL vs INZY

Header iconADIL vs INZY Comparison
Open Charts ADIL vs INZYBanner chart's image
Adial Pharmaceuticals
Price$1.73
Change+$0.02 (+1.17%)
Volume$75.05K
CapitalizationN/A
Inozyme Pharma
Price$4.33
Change-$0.07 (-1.59%)
Volume$407.41K
CapitalizationN/A
View a ticker or compare two or three
ADIL vs INZY Comparison Chart

Loading...

ADILDaily Signal changed days agoGain/Loss if shorted
 
Show more...
INZYDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ADIL vs. INZY commentary
Apr 26, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADIL is a StrongSell and INZY is a Hold.

COMPARISON
Comparison
Apr 26, 2024
Stock price -- (ADIL: $1.73 vs. INZY: $4.33)
Brand notoriety: ADIL and INZY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADIL: 2% vs. INZY: 83%
Market capitalization -- ADIL: $7.01M vs. INZY: $267.47M
ADIL [@Biotechnology] is valued at $7.01M. INZY’s [@Biotechnology] market capitalization is $267.47M. The market cap for tickers in the [@Biotechnology] industry ranges from $562.44B to $0. The average market capitalization across the [@Biotechnology] industry is $2.55B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADIL’s FA Score shows that 1 FA rating(s) are green whileINZY’s FA Score has 1 green FA rating(s).

  • ADIL’s FA Score: 1 green, 4 red.
  • INZY’s FA Score: 1 green, 4 red.
According to our system of comparison, ADIL is a better buy in the long-term than INZY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADIL’s TA Score shows that 4 TA indicator(s) are bullish while INZY’s TA Score has 4 bullish TA indicator(s).

  • ADIL’s TA Score: 4 bullish, 6 bearish.
  • INZY’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both ADIL and INZY are a bad buy in the short-term.

Price Growth

ADIL (@Biotechnology) experienced а -20.28% price change this week, while INZY (@Biotechnology) price change was -5.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.76%. For the same industry, the average monthly price growth was -8.05%, and the average quarterly price growth was +1257.31%.

Reported Earning Dates

ADIL is expected to report earnings on Nov 13, 2023.

INZY is expected to report earnings on Aug 07, 2024.

Industries' Descriptions

@Biotechnology (-0.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ADIL with price predictions.
OPEN
A.I.dvisor published
a Summary for INZY with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
INZY($267M) has a higher market cap than ADIL($7.02M). INZY YTD gains are higher at: 3.286 vs. ADIL (-8.065).
ADILINZYADIL / INZY
Capitalization7.02M267M3%
EBITDAN/AN/A-
Gain YTD-8.0653.286-245%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
ADILINZY
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend about 1 month ago
80%
Bullish Trend 29 days ago
86%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ADILDaily Signal changed days agoGain/Loss if shorted
 
Show more...
INZYDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OTPSX117.150.37
+0.32%
ProFunds NASDAQ-100 Svc
FAPJX11.83N/A
N/A
Fidelity Advisor Healthy Future A
FGFLX37.06-0.05
-0.13%
Federated Hermes Intl Leaders IS
LMGAX21.03-0.07
-0.33%
Lord Abbett Growth Opportunities A
ARTIX28.36-0.38
-1.32%
Artisan International Investor

ADIL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADIL has been loosely correlated with TCON. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ADIL jumps, then TCON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADIL
1D Price
Change %
ADIL100%
+0.59%
TCON - ADIL
39%
Loosely correlated
+2.16%
SYRE - ADIL
39%
Loosely correlated
-3.68%
VANI - ADIL
30%
Poorly correlated
-3.89%
ELOX - ADIL
26%
Poorly correlated
-1.82%
APLMW - ADIL
26%
Poorly correlated
N/A
More

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with BEAM. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
N/A
BEAM - INZY
54%
Loosely correlated
-3.11%
NTLA - INZY
50%
Loosely correlated
-1.67%
DNLI - INZY
47%
Loosely correlated
-3.41%
PCVX - INZY
45%
Loosely correlated
-0.95%
STOK - INZY
44%
Loosely correlated
+3.64%
More